Interestingly, PD-L1-regulated genes encounter on the one hand genes associated with inflammation resulting in the potential to cause an increased sensibility of the tumor to ICB, and on the other hand include other immune checkpoint genes, possibly leading to acquired ICB-resistance [31]. This evidence concerns the gene CD274 and neoplasm.